Entrada Therapeutics, Inc. (TRDA) Balance Sheet Quarterly

Entrada Therapeutics, Inc.

TRDA (NASDAQ)

(%)

Financials
Entrada Therapeutics, Inc. Balance Sheet Statement Quarterly

Annual Quarterly

* (except for per share items) of USD

Period Ending:	2025 (Q3) 09-30	2025 (Q2) 06-30	2025 (Q1) 03-31	2024 (Q4) 12-31	2024 (Q3) 09-30	2024 (Q2) 06-30	2024 (Q1) 03-31
Report Filing:	2025-11-06	2025-08-06	2025-05-08	2025-02-27	2024-11-05	2024-08-13	1234
Total Current Assets	338.3	369.1	403.2	440	465.3	489.5	1234
Cash and Short Term Investments	326.8	354	382.5	420	449.3	469.7	1234
Cash & Equivalents	93.29	72.48	67.84	101.2	78.05	185.3	1234
Short Term Investments	233.6	281.5	314.7	318.8	371.3	284.5	1234
Receivables	3.2	1.18	2.04	3.68	2.6	7.67	1234
Inventory	0	0	0	0	0	0	1234
Other Current Assets	8.22	13.95	18.63	16.36	13.39	12.12	1234
Total Assets	412.9	448.8	486.5	526.3	554.6	582	1234
Total Non-Current Assets	74.64	79.64	83.29	86.28	89.25	92.43	1234
Property, Plant and Equipment	70.53	75.49	79.1	82.05	84.56	87.73	1234
Goodwill and Intangible Assets	0	0	0	0	0	0	1234
Goodwill	0	0	0	0	0	0	1234
Intangible Assets	0	0	0	0	0	0	1234
Long Term Investments	3.95	0	0	0	0	0	1234
Deferred Tax Assets	0	0	0	0	0	0	1234
Other Long Term Assets	0.163	4.15	4.19	4.23	4.7	4.7	1234
Total Current Liabilities	24.02	19.8	18.43	39.48	70.6	85.81	1234
Accounts Payable	3.17	1.86	2.19	4.26	1.29	1.64	1234
Notes Payable/Short Term Debt	4.35	5.46	6.51	7.56	7.74	8.57	1234
Tax Payables	0	0	0.802	0.667	2.25	4.11	1234
Deferred Revenue	0.351	0.689	1.35	13.65	45.92	60.5	1234
Other Current Liabilities	16.15	11.79	7.58	13.34	13.4	11	1234
Total Liabilities	72.18	69.28	69.22	97.64	132.1	152	1234
Total Non-Current Liabilities	48.16	49.48	50.79	58.16	61.54	66.23	1234
Total Long Term Debt	48.05	49.28	50.49	51.65	53.58	55.88	1234
Deferred Tax Liabilities Non-Current	0	0	0	0	0	0	1234
Deferred Revenue Non-Current	0.113	0.194	0.301	6.51	7.96	10.35	1234
Capital Lease Obligations	48.05	54.74	57	59.21	61.31	64.44	1234
Other Long Term Liabilities	-48.05	-54.74	-57	-59.21	-61.31	-64.44	1234
Total Equity	340.7	379.5	417.3	428.7	422.4	429.9	1234
Non-Controlling Interest	0	0	0	0	0	0	1234
Total Stockholders' Equity	340.7	379.5	417.3	428.7	422.4	429.9	1234
Retained Earnings	-233.9	-189.8	-146.7	-129.3	-130.5	-116.4	1234
Accumulated Other Earnings	0.621	0.4	0.437	-0.043	0.972	-0.329	1234
Common Stock	0.004	0.004	0.004	0.004	0.004	0.004	1234
Preferred Stock	0	0	0	0	0	0	1234
Additional Paid in Capital	574	568.9	563.5	558.1	551.9	546.7	1234
Total Liabilities & Total Equity	412.9	448.8	486.5	526.3	554.6	582	1234
Total Liabilities & Shareholders' Equity	412.9	448.8	486.5	526.3	554.6	582	1234
Total Investments	237.5	281.5	314.7	318.8	371.3	284.5	1234
Total Debt	52.4	54.74	57	59.21	61.31	64.44	1234
Net Debt	-40.89	-17.74	-10.84	-42	-16.73	-120.8	1234

Market is Open

After-Hours Quote

Market is Open

After-Hours Quote

Entrada Therapeutics, Inc. Balance Sheet Statement Quarterly